Maynard Um
-
-
-
-
-
-
-
Niagen Bioscience launches drug candidate for rare genetic disease
-
-
-
-
-
-
-
Niagen Bioscience launches telehealth platform with at-home injection kit
-
-
-
-
-
-
-
Niagen Bioscience receives US patent for IV nicotinamide riboside
-
-
-
-
-
-
-
Niagen Bioscience (NAGE) PT Raised to $12 at H.C. Wainwright
-
-
-
-
-
-
-
Niagen Bioscience (NAGE) announces Niagen IV is available in nearly 600 clinics
-
-
-
-
-
-
427,656 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

